jofinЖурнал инфектологииJournal Infectology2072-6732IPO “АIDSSPbR"10.22625/2072-6732-2020-12-2-12-18jofin-1042Research ArticleОбзорыReviewЛечебно-диагностическая тактика при заболеваниях легких у больных Вич-инфекцией (обзор литературы)Clinical approach to lung diseases in HIV-infected patients (review)ВиктороваИ. Б.ViktorovaI. B.

доцент кафедры фтизиопульмонологии, к.м.н.

тел./факс: 8(3843)45-42-19

Новокузнецк

Novokuznetsk

irinaviktoroff@mail.ruЗиминаВ. Н.ZiminaV. N.

профессор кафедры инфекционных болезней с курсами эпидемиологиии фтизиатрии медицинского института, д.м.н.

тел./факс: 8(495)365-25-33Москва

Moscow

vera-zim@yandex.ruДегтяреваС. Ю.DegtyarevaS. Yu.

ассистент кафедры инфекционных болезней с курсами эпидемиологиии фтизиатрии медицинского института 

тел./факс: 8(495)365-25-33Москва

Moscow

degtyareva_svet@mail.ruКравченкоА. В.KravtchenkoA. V.

ведущий научный сотрудник, д.м.н., профессор

Москва

Moscow

kravtchenko@hivrussia.netНовокузнецкий государственный институт усовершенствования врачей – филиал Российской медицинской академии непрерывного профессионального образованияРоссияNovokuznetsk State Institute for Further Training of Physicians – Branch Campus of Russian Medical Academy of Continuous Professional EducationRussian FederationРоссийский университет дружбы народовРоссияPeoples’ Friendship University of RussiaRussian FederationЦентральный научно-исследовательский институт эпидемиологииРоссияСentral Research Institute of EpidemiologyRussian Federation2020160620201221218Copyright © Викторова И.Б., Зимина В.Н., Дегтярева С.Ю., Кравченко А.В., 20202020Викторова И.Б., Зимина В.Н., Дегтярева С.Ю., Кравченко А.В.Viktorova I.B., Zimina V.N., Degtyareva S.Y., Kravtchenko A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.niidi.ru/jofin/article/view/1042ВИЧ-инфекциявторичные инфекциитуберкулезпневмоцистная пневмониялимфомаHIV-infectionopportunistic lung infectionstuberculosispneumocystis pneumoniaReferencesКалачева, Г.А. Аналитический обзор эпидемии ВИЧинфекции в Сибирском федеральном округе в 2014 г. : монография / Г.А. Калачева, А.Т. Тюменцев, Е.С. Довгополюк. – Омск: ООО Издательский центр «Омский научный вестник», 2015. – 31 с.Kalacheva G.A. Analiticheskij obzor epidemii VICH-infekcii v Sibirskom federal’nom okruge v 2014 g: monografiya / Kalacheva G.A., Tyumencev A.T., Dovgopolyuk E.S. – Omsk: ООО Izdatel’skij centr «Omskij nauchnyj vestnik», 2015. – 31 p. (in Russian).Ермак, Т.Н. Анализ причин летальных исходов больных ВИЧ-инфекцией в Российской Федерации / Т.Н. Ермак, А.В. Кравченко, В.И. Шахгильдян // Инфекционные болезни. – 2010. – № 3. – С. 19–20.Ermak T.N. Analiz prichin letal’nyh iskhodov bol’nyh VICH-infekciej v Rossijskoj Federacii / Ermak T.N., Kravchenko A.V., Shakhgil’dian V.I. // Infekcionnye bolezni. – 2010. – № 3. – p. 19–20. (in Russian).Кожевникова, Г.М. Прогностические факторы благоприятного исхода лечения больных ВИЧ-инфекцией в отделении интенсивной терапии / Г.М. Кожевникова [и др.] // Инфекционные болезни. – 2017. – № 15(3). – С. 20–24.Kozhevnikova G.M., Voznesenskiy S.L., Ermak T.N., Smetanina S.V., Petrova E.V., Samotolkina E.A. Prognostic factors of a favourable outcome of treating HIV-infected patients in an intensive care unit. Infekc. bolezni (Infectious diseases). 2017; 15(3): 20–24. (In Russian).Тютрина, В.Д. ВИЧ-инфицированные пациенты в многопрофильной больнице / В.Д. Тютрина [и др.] // Медицина в Кузбассе. – 2013. – № 2. – С. 74–78.Tyutrina V.D. VICH-inficirovannye pacienty v mnogoprofil’noj bol’nice / Tyutrina V.D., Bayanova T.A., Botvinkin A.D., Makarova K.A., Talikina T.O., Khagdaeva E.G. // Medicina v Kuzbasse. – 2013. – N2. – S. 74–8. (in Russian).Евстигнеев, И.В. Легочная патология у ВИЧинфицированных в практике терапевта / И.В. Евстигнеев [и др.] // Украiнский терапевтичний журнал. – 2011. – № 1. – С. 70–75.Evstigneev I.V. Legochnaya patologiya u VICH-inficirovannyh v praktike terapevta / Evstigneev I.V., Makhova I.B., Vasilenko P.I., Grishnyakova A.A., Yarchenko L.I.. Maksimovich T.I. // Ukrainskij terapevtichnij zhurnal. – 2011. – №1. – S. 70–75. (in Russian).Sarkar P, Rasheed HF. Clinical review: Respiratory failure in HIV-infected patients--a changing picture. Crit Care. 2013 Jun;17(3):228.Sarkar P, Rasheed HF. Clinical review: Respiratory failure in HIV-infected patients--a changing picture. Crit Care. 2013 Jun;17(3):228.Ладная, Н.Н. Развитие Эпидемии ВИЧ-инфекции в Российской Федерации в 2015 г / Н.Н. Ладная [и др.] // Материалы научно-практической конференции «Актуальные вопросы ВИЧ-инфекции». – СПб: ООО «Человек и его здоровье», 2016. – С. 4–9.Ladnaya N.N. Razvitie epidemii VICH-infekcii v Rossijskoj Federacii v 2015 g / Ladnaya N.N., Pokrovsky V.V., Dement’yeva L.A., Simashev T.N., Lipina E.S., Yurin O.G. // Materialy nauchno-prakticheskoj konferencii «Aktual’nye voprosy VICH-infekcii». – SPb: OOO «CHelovek i ego zdorov’e», 2016. – S. 4–9. (in Russian).Покровский, В.В. Инфекция, вызываемая вирусом иммунодефицита человека, в России / В.В. Покровский // Терапевтеческий архив. – 2016. – № 88, Т. 11. – С. 4–11.Pokrovsky V.V. Infekciya, vyzyvaemaya virusom immunodeficita cheloveka, v Rossii / Pokrovsky V.V. // Terapevtecheskij arhiv. – 2016. – №88 Т.11. – S. 4–11. (in Russian).Ермак, Т.Н. Оппортунистические (вторичные) заболевания у больных ВИЧ–инфекцией в Российской Федерации: структура, клиническая диагностика, лечение. Часть 1. Туберкулез и пневмоцистная пневмония / Т.Н. Ермак // Фарматека. – 2010. – 4. – С. 52–56.Ermak T.N. pportunisticheskie (vtorichnye) zabolevaniya u bol’nyh VICH–infekciej v Rossijskoj Federacii: struktura, klinicheskaya diagnostika, lechenie. CHast’ 1.Бабаева, И.Ю. Патоморфологическеи особенности туберкулеза легких на разных стадиях ВИЧ-инфекции (по данным аутопсии) / И.Ю. Бабаева, З.С. Земскова, Л.Е. Гедымин // Проблемы туберкулеза. – 2007 . – 12. – С. 38–41.Tuberkulez i pnevmocistnaya pnevmoniya / Ermak T.N. // Farmateka. – 2010. – 4. – S. 52–56. (in Russian).Пархоменко, Ю.Г. Дифференциальная диагностика деструктивных поражений легких при ВИЧ-ассоциированных инфекциях / Ю.Г. Пархоменко, Ю.Р. Зюзя, Д.М. Флигиль // Архив патологии. – 2011. – 1. – С. 9–12.Babaeva I.Yu. Patomorfologicheskei osobennosti tuberkuleza legkih na raznyh stadiyah VICH-infekcii (po dannym autopsii) / Babaeva I.Yu., Zemskova Z.S., Gedimin L.E. // Problemy tuberkuleza. – 2007 . – 12. – S. 38–41. (in Russian).Narayanswami G, Salzman SH. Bronchoscopy in the human immunodeficiency virus-infected patient. Semin Respir Infect. 2003 Jun;18(2):80–6.Parkhomenko Yu.G. Differencial’naya diagnostika destruktivnyh porazhenij legkih pri VICH-associirovannyh infekciyah / Parkhomenko Yu.G., Zyuzya Yu.R., Fligil’ D.M. // Arhiv patologii. – 2011. – 1. – S. 9–12. (in Russian).Benito N, Rañó A, Moreno A, González J, Luna M, Agustí C, et al. Pulmonary Infiltrates in HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era in Spain. JAIDS J Acquir Immune Defic Syndr [Internet]. 2001;27:35–43. Available from: https://journals.lww.com/jaids/Fulltext/2001/05010/Pulmonary_Infiltrates_in_HIV_Infected_Patients_in.6.aspxNarayanswami G, Salzman SH. Bronchoscopy in the human immunodeficiency virus-infected patient. Semin Respir Infect. 2003 Jun;18(2):80–6.Tu JV, Biem HJ, Detsky AS. Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis. Am Rev Respir Dis. 1993 Aug;148(2):370–7.Benito N, Rañó A, Moreno A, González J, Luna M, Agustí C, et al. Pulmonary Infiltrates in HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era in Spain. JAIDS J Acquir Immune Defic Syndr [Internet]. 2001;27:35–43. Available from: https://journals.lww.com/jaids/Fulltext/2001/05010/Pulmonary_Infiltrates_in_HIV_Infected_Patients_in.6.aspxПузырёва, Л.В. Заболевания органов дыхания при ВИЧинфекции (обзор) / Л.В. Пузырёва, А.Д. Сафонов, А.В. Мордык // Журнал инфектологии. – 2016. – № 8, Т. 2. – С. 17–25.Tu J V, Biem HJ, Detsky AS. Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis. Am Rev Respir Dis. 1993 Aug;148(2):370–7.Murray JF. Pulmonary complications of HIV-1 infection among adults living in Sub-Saharan Africa. Int J Tuberc Lung Dis. 2005 Aug;9(8):826–35.Puzireva L.V. Zabolevaniya organov dyhaniya pri VICH-infekcii (obzor) / Puzireva L.V., Safonov A.D., Mordik A.V. // Zhurnal infektologii – 2016. – №8 Т. 2. – S. 17–25. (in Russian).Walusimbi S, Semitala F, Bwanga F, Haile M, De Costa A, Davis L, et al. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study. Pan Afr Med J [Internet]. 2016 Mar 31;23:154. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27303572Murray JF. Pulmonary complications of HIV-1 infection among adults living in Sub-Saharan Africa. Int J Tuberc Lung Dis. 2005 Aug;9(8):826–35.Schleenvoigt BT, Rupp J, Rohde G, Rockstroh JK, Fatkenheuer G, Pletz MW. Strategies for the Treatment of Community-Acquired Pneumonia in HIV-Positive Patients. Pneumologie. 2017 Apr;71(4):207–14.Walusimbi S, Semitala F, Bwanga F, Haile M, De Costa A, Davis L, et al. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study. Pan Afr Med J [Internet]. 2016 Mar 31;23:154. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27303572WHO. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: Recommendations for HIVprevalent and resource-constrained settings. [Internet]. 2007. [cited 04.09.2019]. Available from: https://apps.who.int/iris/bitstream/handle/10665/69463/WHO_HTM_TB_2007.379_eng.pdf?sequence=1Schleenvoigt BT, Rupp J, Rohde G, Rockstroh JK, Fatkenheuer G, Pletz MW. Strategies for the Treatment of Community-Acquired Pneumonia in HIV-Positive Patients. Pneumologie. 2017 Apr;71(4):207–14.Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD, Santos Filho ED, et al. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis. 2011 Mar;15(3):287–95.WHO. Improving the diagnosis and treatment of smearnegative pulmonary and extrapulmonary tuberculosis among adults and adolescents: Recommendations for HIV-prevalent and resource-constrained settings. [Internet]. 2007. [cited 2019 Sep 4]. Available from:https://apps.who.int/iris/bitstream/handle/10665/69463/WHO_HTM_TB_2007.379_eng.pdf?sequence=1Katagira W, Walter ND, Den Boon S, Kalema N, Ayakaka I, Vittinghoff E, et al. Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival. J Acquir Immune Defic Syndr. 2016 Jul;72(3):297–303.Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD, Santos Filho ED, et al. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis. 2011 Mar;15(3):287–95.Schleicher GK, Hopley MJ, Feldman C. CD4 T-lymphocyte subset counts in HIV-seropositive patients during the course of community-acquired pneumonia caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2004 Jun;10(6):587–9.Katagira W, Walter ND, Den Boon S, Kalema N, Ayakaka I, Vittinghoff E, et al. Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival. J Acquir Immune Defic Syndr. 2016 Jul;72(3):297–303.Ferrand H, Crockett F, Naccache J-M, Rioux C, Mayaud C, Yazdanpanah Y, et al. Pulmonary manifestations in HIVinfected patients: a diagnostic approach. Rev Mal Respir. 2014 Dec;31(10):903–15.Schleicher GK, Hopley MJ, Feldman C. CD4 T-lymphocyte subset counts in HIV-seropositive patients during the course of community-acquired pneumonia caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2004 Jun;10(6):587–9.Gallant JE, Ko AH. Cavitary pulmonary lesions in patients infected with human immunodeficiency virus. Clin Infect Dis. 1996 Apr;22(4):671–82.Ferrand H, Crockett F, Naccache J-M, Rioux C, Mayaud C, Yazdanpanah Y, et al. Pulmonary manifestations in HIVinfected patients: a diagnostic approach. Rev Mal Respir. 2014 Dec;31(10):903–15.Allen CM, Al-Jahdali HH, Irion KL, Al Ghanem S, Gouda A KA. Imaging lung manifestations of HIV/AIDS. Ann Thorac Med. 2010;5(4):201–16.Gallant JE, Ko AH. Cavitary pulmonary lesions in patients infected with human immunodeficiency virus. Clin Infect Dis. 1996 Apr;22(4):671–82.Boiselle PM, Tocino I, Hooley RJ, Pumerantz AS, Selwyn PA, Neklesa VP, et al. Chest radiograph interpretation of Pneumocystis carinii pneumonia, bacterial pneumonia, and pulmonary tuberculosis in HIV-positive patients: accuracy, distinguishing features, and mimics. J Thorac Imaging. 1997 Jan;12(1):47–53.Allen CM, Al-Jahdali HH, Irion KL, Al Ghanem S, Gouda A KA. Imaging lung manifestations of HIV/AIDS. Ann Thorac Med. 2010;5(4):201–16.Marchiori E, Muller NL, Soares Souza AJ, Escuissato DL, Gasparetto EL, Franquet T. Pulmonary disease in patients with AIDS: high-resolution CT and pathologic findings. AJR Am J Roentgenol. 2005 Mar;184(3):757–64.Boiselle PM, Tocino I, Hooley RJ, Pumerantz AS, Selwyn PA, Neklesa VP, et al. Chest radiograph interpretation of Pneumocystis carinii pneumonia, bacterial pneumonia, and pulmonary tuberculosis in HIV-positive patients: accuracy, distinguishing features, and mimics. J Thorac Imaging. 1997 Jan;12(1):47–53.Mathur M, Badhan RK, Kumari S, Kaur N, Gupta S. Radiological Manifestations of Pulmonary Tuberculosis – A Comparative Study between Immunocompromised and Immunocompetent Patients. J Clin Diagn Res. 2017 Sep;11(9):TC06–9.Marchiori E, Muller NL, Soares Souza AJ, Escuissato DL, Gasparetto EL, Franquet T. Pulmonary disease in patients with AIDS: high-resolution CT and pathologic findings. AJR Am J Roentgenol. 2005 Mar;184(3):757–64.Kim B, Kim J, Paik SS, Pai H. Atypical Presentation of Pneumocystis jirovecii Infection in HIV Infected Patients: Three Different Manifestations. Vol. 33, Journal of Korean medical science. Korea (South); 2018. p. e115.Mathur M, Badhan RK, Kumari S, Kaur N, Gupta S. Radiological Manifestations of Pulmonary Tuberculosis – A Comparative Study between Immunocompromised and Immunocompetent Patients. J Clin Diagn Res. 2017 Sep;11(9):TC06–9.Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medical Association of the [Internet]. 2019 [cited 2019 Jul 15]. p. 423. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 5/24/2019.Kim B, Kim J, Paik SS, Pai H. Atypical Presentation of Pneumocystis jirovecii Infection in HIV Infected Patients: Three Different Manifestations. Vol. 33, Journal of Korean medical science. Korea (South); 2018. p. e115.Викторова, И.Б. Диссеминированные заболевания легких у пациентов с различным ВИЧ-статусом: учебное пособие в алгоритмах / И.Б. Викторова [и др.]. – М.: ГЭОТАР-Медиа, 2017. – 248 с.Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medical Association of the [Internet]. 2019 [cited 2019 Jul 15]. p. 423. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 5/24/2019.Fox GJ, Benedetti A, Cox H, Koh W-J, Viiklepp P, Ahuja S, et al. Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2017 Jan;49(1).Viktorova I.B. Disseminirovannye zabolevaniya legkih u pacientov s razlichnym VICH-statusom: uchebnoe posobie v algoritmah / Viktorova I.B., Zimina V.N., Kravchenko A.V., Khanin A.L. – М.: GEOTAR-Media, 2017. – 248 p. (in Russian).WHO. WHO consolidated guidelines on drug-resistant tuberculosis treatment. [Internet]. 2019 [cited 08.09.2019]. p. 99. Available from: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf?ua=1Fox GJ, Benedetti A, Cox H, Koh W-J, Viiklepp P, Ahuja S, et al. Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2017 Jan;49(1).Викторова, И.Б. Бактериовыделение у пациентов с ВИЧ-инфекцией и туберкулезом / И.Б. Викторова [и др.] // Эпидемиология и инфекционные болезни. Актуальные вопросы. – 2018. – № 3. – С. 35–40.WHO. WHO consolidated guidelines on drug-resistant tuberculosis treatment. [Internet]. 2019 [cited 2019 Sep 8]. p.99. Available from: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf?ua=1van der Heijden YF, Maruri F, Blackman A, Mitchel E, Bian A, Shintani AK, et al. Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to olderversus newer-generation fluoroquinolones. Int J Antimicrob Agents [Internet]. 2013/06/24. 2013 Sep;42(3):232–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23806638Viktorova I.B. Bakteriovydelenie u pacientov s VICHinfekciej i tuberkulezom / Viktorova I.B., Zimina V.N., Kravchenko A.V., Khanin A.L. // Epidemiologiya i infekcionnye bolezni. Aktual’nye voprosy. – 2018. – T. 3. – S. 35–40. (in Russian).Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure. Am J Respir Crit Care Med. 2009 Aug;180(4):365–70.van der Heijden YF, Maruri F, Blackman A, Mitchel E, Bian A, Shintani AK, et al. Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to olderversus newer-generation fluoroquinolones. Int J Antimicrob Agents [Internet]. 2013/06/24. 2013 Sep;42(3):232–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/23806638Migliori GB, Langendam MW, D’Ambrosio L, Centis R, Blasi F, Huitric E, et al. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J. 2012 Oct;40(4):814–22.Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure. Am J Respir Crit Care Med. 2009 Aug;180(4):365–70.Chen T-C, Lu P-L, Lin C-Y, Lin W-R, Chen Y-H. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2011 Mar;15(3):e211-6.Migliori GB, Langendam MW, D’Ambrosio L, Centis R, Blasi F, Huitric E, et al. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J. 2012 Oct;40(4):814–22.Chen T-C, Lu P-L, Lin C-Y, Lin W-R, Chen Y-H. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2011 Mar;15(3):e211-6.Chen T-C, Lu P-L, Lin C-Y, Lin W-R, Chen Y-H. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2011 Mar;15(3):e211-6.

The authors declare that there are no conflicts of interest present.